U.S. regulators on Thursday listed two dozen drugs, including weight-loss medicines and sleep disorder pills, that it is reviewing for potential safety problems.
Many of the issues have been disclosed previously, but the Food and Drug Administration continues to review them.
The FDA is checking Pfizer Inc.'s smoking cessation drug Chantix for possible risk of accidental injury, vision impairment and other issues, and Cephalon Inc.'s sleep disorder drugs Nuvigil and Provigil for a potential of serious skin reactions.
Other drugs listed included orlistat, a weight-loss drug that Roche Inc. sells as the prescription product Xenical and GlaxoSmithKline Plc sells as the over-the-counter drug Alli. The FDA said it is continuing to evaluate liver toxicity reports for orlistat. MORE>>>>>>>>>>>